{"organizations": [], "uuid": "5bf3bef14d739cd52faed165a8efe677fb0058e9", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180419.html", "section_title": "Archive News &amp; Video for Thursday, 19 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-glenmark-pharmaceuticals-gets-anda/brief-glenmark-pharmaceuticals-gets-anda-approval-for-clobetasol-propionate-topical-solution-usp-idUSFWN1RW0ZG", "country": "US", "domain_rank": 408, "title": "BRIEF-Glenmark Pharmaceuticals Gets ANDA Approval For Clobetasol Propionate Topical Solution USP", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.932, "site_type": "news", "published": "2018-04-20T11:13:00.000+03:00", "replies_count": 0, "uuid": "5bf3bef14d739cd52faed165a8efe677fb0058e9"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-glenmark-pharmaceuticals-gets-anda/brief-glenmark-pharmaceuticals-gets-anda-approval-for-clobetasol-propionate-topical-solution-usp-idUSFWN1RW0ZG", "ord_in_thread": 0, "title": "BRIEF-Glenmark Pharmaceuticals Gets ANDA Approval For Clobetasol Propionate Topical Solution USP", "locations": [], "entities": {"persons": [], "locations": [{"name": "co", "sentiment": "none"}, {"name": "india", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "glenmark pharmaceuticals ltd", "sentiment": "negative"}, {"name": "anda approval for clobetasol propionate topical solution usp", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 20 (Reuters) - Glenmark Pharmaceuticals Ltd:\n* GETS ANDA APPROVAL FOR CLOBETASOL PROPIONATE TOPICAL SOLUTION USP\n* SAYS PRODUCT WILL BE MANUFACTURED AT CO'S BADDI PLANT IN INDIA Source text - bit.ly/2F0WQol Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "http://bit.ly/2F0WQol", "https://instagram.com/reuters/"], "published": "2018-04-20T11:13:00.000+03:00", "crawled": "2018-04-20T11:32:23.001+03:00", "highlightTitle": ""}